Bliss GVS Pharma Ltd NSE  /  BSE

Pharmaceuticals, Mid Cap

18 Jun 2018 | 02:37 PM

190.85
4.80 (2.58%)

  • Outperforms Index

    15.14%

    Return (1Y)

    Beaten S&P BSE Healthcare by 15.59%

  • More Volatile

    1.94%

    Standard Deviation (1Y)

    Higher than S&P BSE Healthcare by 0.86%

  • Not so consistent

    6/12

    Months

    underperformed S&P BSE Healthcare

  • AxisDirect View

    No View

52 Week High-Low

230

230.00

146

146.40

News & Announcements

Price vs Volume

Stock Trivia

  • FII shareholding in Bliss GVS Pharma Ltd has increased by 42.03% since past 3 Months

  • FII shareholding in Bliss GVS Pharma Ltd has increased by 99.15% since past 1 Year

  • MF shareholding in Bliss GVS Pharma Ltd has decreased by -100% since past 1 Year

Loading...